Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...

“There is still no AI-generated small molecule drug treating patients ... an unprecedented rate there is no telling where the future of AI in the drug discovery space could lead,” said Wang. “As well ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

Regional Analysis: North America holds 40% of the Generative AI Life Sciences market... Lawrence John Prudour +91 91308 55334 ...

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...

BenevolentAI has entered a two-year agreement with the MRC Technology to investigate new small molecule and antibody drug candidates ... s screening and hit to lead capabilities, is powerful ...